- Home
- UTF vs BHC Comparison
UTF vs BHC Comparison
Compare UTF & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UTF | BHC |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | UTF | BHC |
|---|---|---|
| Price | $26.54 | $6.07 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $8.67 |
| AVG Volume (30 Days) | 171.7K | ★ 2.2M |
| Earning Date | 01-01-0001 | 02-18-2026 |
| Dividend Yield | ★ 7.19% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.84 | 0.97 |
| Revenue | $138,636,669.00 | ★ $10,029,000,000.00 |
| Revenue This Year | N/A | $6.81 |
| Revenue Next Year | N/A | $4.11 |
| P/E Ratio | $9.16 | ★ $6.37 |
| Revenue Growth | ★ 19.80 | 5.86 |
| 52 Week Low | $22.05 | $4.25 |
| 52 Week High | $26.53 | $8.69 |
Technical Indicators
Market Signals| Indicator | UTF | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 79.34 | 43.63 |
| Support Level | $25.84 | $5.62 |
| Resistance Level | $26.27 | $6.31 |
| Average True Range (ATR) | 0.27 | 0.20 |
| MACD | 0.06 | 0.04 |
| Stochastic Oscillator | 90.52 | 68.42 |
Price Performance
Historical ComparisonAbout UTF Cohen & Steers Infrastructure Fund Inc
Cohen & Steers Infrastructure Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is total return with an emphasis on income. It invests majority of its managed assets in securities issued by infrastructure companies, which consists of utilities, pipelines, toll roads, airports, railroads, ports, telecommunications companies, and other infrastructure companies, under normal market conditions.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.